FR20C1016I2 - Vaccins recombinants issu du virus de la stomatite vesiculaire dirige contre les fievres hemorragiques virales - Google Patents
Vaccins recombinants issu du virus de la stomatite vesiculaire dirige contre les fievres hemorragiques viralesInfo
- Publication number
- FR20C1016I2 FR20C1016I2 FR20C1016C FR20C1016C FR20C1016I2 FR 20C1016 I2 FR20C1016 I2 FR 20C1016I2 FR 20C1016 C FR20C1016 C FR 20C1016C FR 20C1016 C FR20C1016 C FR 20C1016C FR 20C1016 I2 FR20C1016 I2 FR 20C1016I2
- Authority
- FR
- France
- Prior art keywords
- vesicular stomatitis
- stomatitis virus
- against viral
- viral hemorrhagic
- recombinant vaccines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/10011—Arenaviridae
- C12N2760/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/14011—Filoviridae
- C12N2760/14111—Ebolavirus, e.g. Zaire ebolavirus
- C12N2760/14134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/14011—Filoviridae
- C12N2760/14211—Marburgvirus, e.g. lake Victoria marburgvirus
- C12N2760/14234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20211—Vesiculovirus, e.g. vesicular stomatitis Indiana virus
- C12N2760/20221—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20211—Vesiculovirus, e.g. vesicular stomatitis Indiana virus
- C12N2760/20222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20211—Vesiculovirus, e.g. vesicular stomatitis Indiana virus
- C12N2760/20232—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20211—Vesiculovirus, e.g. vesicular stomatitis Indiana virus
- C12N2760/20241—Use of virus, viral particle or viral elements as a vector
- C12N2760/20243—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39855202P | 2002-07-26 | 2002-07-26 | |
PCT/CA2003/001125 WO2004011488A2 (fr) | 2002-07-26 | 2003-07-28 | Vaccins recombinants issu du virus de la stomatite vesiculaire dirige contre les fievres hemorragiques virales |
Publications (2)
Publication Number | Publication Date |
---|---|
FR20C1016I1 FR20C1016I1 (fr) | 2020-06-12 |
FR20C1016I2 true FR20C1016I2 (fr) | 2022-04-01 |
Family
ID=31188416
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR20C1016C Active FR20C1016I2 (fr) | 2002-07-26 | 2020-05-06 | Vaccins recombinants issu du virus de la stomatite vesiculaire dirige contre les fievres hemorragiques virales |
Country Status (9)
Country | Link |
---|---|
US (1) | US8012489B2 (fr) |
EP (1) | EP1527087B2 (fr) |
AT (1) | ATE455124T1 (fr) |
AU (1) | AU2003250680A1 (fr) |
CA (1) | CA2493142C (fr) |
DE (1) | DE60330966D1 (fr) |
ES (1) | ES2338416T5 (fr) |
FR (1) | FR20C1016I2 (fr) |
WO (1) | WO2004011488A2 (fr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009116983A2 (fr) * | 2007-12-18 | 2009-09-24 | Trustees Of Boston University | Compositions et méthodes de traitement de l'infection par le virus ebola |
WO2009116982A2 (fr) | 2007-12-18 | 2009-09-24 | Trustees Of Boston University | Traitement pré-exposition ou post-exposition pour l'infection par filovirus ou arénavirus |
CA2741523C (fr) | 2008-10-24 | 2022-06-21 | Jonathan S. Towner | Espece de virus ebola humain et compositions et procedes associes |
WO2010142030A1 (fr) * | 2009-06-08 | 2010-12-16 | The University Of Western Ontario | Différents sérotypes du virus de la stomatite vésiculaire en tant que vecteurs d'expression pour des régimes d'immunisation |
WO2012170814A1 (fr) * | 2011-06-08 | 2012-12-13 | The Ohio State University | Immunogènes de norovirus, et matériaux et procédés associés |
US9474796B2 (en) | 2012-08-14 | 2016-10-25 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Crimean-Congo hemorrhagic fever virus vaccine |
US9795665B2 (en) | 2012-08-14 | 2017-10-24 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Attenuated live vaccine for Crimean-Congo hemorrhagic fever virus and Erve virus |
WO2015077714A1 (fr) | 2013-11-22 | 2015-05-28 | Yale University | Compositions de virus vsv chimérique et procédés pour les utiliser pour le traitement du cancer |
WO2018111735A1 (fr) * | 2016-12-15 | 2018-06-21 | Merck Sharp & Dohme Corp. | Dosage de rapporteur basé sur des cellules pour vaccins à virus vivant |
WO2019055768A1 (fr) * | 2017-09-15 | 2019-03-21 | Ohio State Innovation Foundation | Vaccins et procédés de fabrication et d'utilisation de vaccins pour la prévention d'infections par le virus respiratoire syncytial (rsv) |
US11274282B2 (en) | 2019-05-15 | 2022-03-15 | Board Of Regents, The University Of Texas System | Vesicular stomatitis vectors encoding Crimean-Congo hemorrhagic fever antigen |
US20230149536A1 (en) | 2020-04-17 | 2023-05-18 | Vyriad, Inc. | Compositions for treating and/or preventing coronavirus infections |
EP4136457A1 (fr) | 2020-04-17 | 2023-02-22 | Regeneron Pharmaceuticals, Inc. | Dosages de détection pour des anticorps neutralisant le coronavirus |
-
2003
- 2003-07-28 AU AU2003250680A patent/AU2003250680A1/en not_active Abandoned
- 2003-07-28 WO PCT/CA2003/001125 patent/WO2004011488A2/fr not_active Application Discontinuation
- 2003-07-28 ES ES03771017T patent/ES2338416T5/es not_active Expired - Lifetime
- 2003-07-28 DE DE60330966T patent/DE60330966D1/de not_active Expired - Lifetime
- 2003-07-28 AT AT03771017T patent/ATE455124T1/de not_active IP Right Cessation
- 2003-07-28 CA CA2493142A patent/CA2493142C/fr not_active Expired - Lifetime
- 2003-07-28 US US10/522,134 patent/US8012489B2/en not_active Expired - Lifetime
- 2003-07-28 EP EP03771017.5A patent/EP1527087B2/fr not_active Expired - Lifetime
-
2020
- 2020-05-06 FR FR20C1016C patent/FR20C1016I2/fr active Active
Also Published As
Publication number | Publication date |
---|---|
ATE455124T1 (de) | 2010-01-15 |
AU2003250680A8 (en) | 2004-02-16 |
US20060193872A1 (en) | 2006-08-31 |
EP1527087B1 (fr) | 2010-01-13 |
CA2493142A1 (fr) | 2004-02-05 |
WO2004011488A9 (fr) | 2004-06-03 |
FR20C1016I1 (fr) | 2020-06-12 |
DE60330966D1 (de) | 2010-03-04 |
AU2003250680A1 (en) | 2004-02-16 |
ES2338416T3 (es) | 2010-05-07 |
CA2493142C (fr) | 2013-11-12 |
EP1527087A2 (fr) | 2005-05-04 |
US8012489B2 (en) | 2011-09-06 |
ES2338416T5 (es) | 2013-11-20 |
WO2004011488A2 (fr) | 2004-02-05 |
EP1527087B2 (fr) | 2013-07-17 |
WO2004011488A3 (fr) | 2004-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR20C1016I2 (fr) | Vaccins recombinants issu du virus de la stomatite vesiculaire dirige contre les fievres hemorragiques virales | |
IL238584A0 (en) | Highly calibrated recombinant influenza viruses for use in vaccines and gene therapy | |
HK1214298A1 (zh) | 用於疫苗和基因治療的重組流感病毒 | |
IL163646A0 (en) | Recombinant parainfluenza virus expression systemsand vaccines comprising heterologous antigens derived from metapneumovirus | |
UA85536C2 (en) | Viral antigens | |
EP1622574A4 (fr) | Systemes d'expression de virus parainfluenza recombinant et vaccins comportant des antigenes heterologues derives du metapneumovirus | |
HK1127370A1 (en) | Mutant vesicular stomatitis viruses and use thereof | |
ZA201009135B (en) | Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases | |
IS7830A (is) | Bóluefni gegn lifrarbólgu C veiru (HCV) | |
WO2008103380A3 (fr) | Compositions contre le virus de l'hépatite b, et procédés d'utilisation | |
AU2003256912A8 (en) | Tumor associated antigen, peptides thereof, and use of same as anti-tumor vaccines | |
AU2003279240A8 (en) | Methods for purifying viral particles for gene therapy | |
AR004464A1 (es) | Un metodo para producir una proteina de capside de papilomavirus | |
EP1485488A4 (fr) | Systemes et vaccins d'expression d'arn a brin negatif recombinant | |
ATE408013T1 (de) | Infektiöses cdna klon des gb-virus b und dessen verwendungen | |
EP1439856A4 (fr) | Vaccin antirabique recombine, preparation et utilisation de ce vaccin | |
AU2002318104A1 (en) | Microparticles and methods for delivery of recombinant viral vaccines | |
IL151033A0 (en) | Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use | |
AU2003293807A1 (en) | Mhc class i restricted t-cell stimulating peptides from hepatitis b virus | |
TR200201954T2 (tr) | Viral hastalıklar için tıbbi maddeler. | |
GB0213446D0 (en) | Methods for making recombinant viruses and vaccines |